Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant,
                    <i>EGFR</i>
                    -Mutated Non–Small Cell Lung Cancer

v1

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR -Mutated Non–Small Cell Lung Cancer

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CCD5B0EB.svg?ark=w1%2F20260526%2FCCD5B0EB)](https://nobleid.org/work/w1/20260526/CCD5B0EB)

Authors & Claims

Paper Authors